SAM
PCVX icon

Shell Asset Management’s Vaxcyte PCVX Stock Holding History

Shell Asset Management’s Portfolio PCVX Stock Details PCVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$25K Sell
689
-1,221
-64% -$40.5K ﹤0.01% 1005
2025
Q2 		$62K Sell
1,910
-210
-10% -$6.88K ﹤0.01% 1108
2025
Q1 		$80K Buy
+2,120
New +$170K ﹤0.01% 1060

Other funds holding PCVX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Shell Asset Management's PCVX Position: Q3 2025 in Review

Shell Asset Management reduced its Vaxcyte (PCVX) stake by 64% in Q3 2025, selling an estimated $40.5K and leaving 689 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #1005.

Shell Asset Management first reported a position in PCVX in Q1 2025 and has held it in 3 quarters since. The position peaked at $80K in Q1 2025. 285 funds tracked by Wall St. Rank hold PCVX as of Q3 2025.

  • Shell Asset Management held 689 shares of Vaxcyte worth $25K as of Q3 2025.
  • Shell Asset Management sold 1,221 Vaxcyte shares in Q3 2025, an estimated $40.5K.
  • Vaxcyte made up ﹤0.01% of Shell Asset Management's portfolio in Q3 2025, its #1005 holding.
  • Shell Asset Management first reported a position in Vaxcyte in Q1 2025 and has held it in 3 quarters since.
  • Shell Asset Management's Vaxcyte position peaked at $80K in Q1 2025.
  • 285 funds tracked by Wall St. Rank held Vaxcyte as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.